Early Research Suggests a Path to Predict and Prevent Lung Cancer

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
ascopubs.org

Advancements in Interoperability: Achieving Anatomic Pathology Reports That Adhere to International Standards and Are Both Human-Readable and Readily Computable

Over the past 50 years, multiple pathology organizations worldwide have evolved in cancer histopathology reporting from subjective, narrative assessments to structured, synoptic formats using ...
ascopubs.org

Usage of the National Cancer Institute Cancer Research Data Commons by Researchers: A Scoping Review of the Literature

Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials? A thorough literature search was ...
Bloomberg L.P.

GSK, iTeos Lung Cancer Data Set to Reignite Hope for Drug Class

Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious optimism around a class of immunotherapy drugs that has suffered a series of ...
Cure Today

5 Breast Cancer Study Results Set to Watch For at ASCO 2026

Phase 3 lidERA evaluates daily oral SERD giredestrant in ER+/HER2- early disease, including subgroup analyses by age and menopausal status after a reported 30% risk reduction. Primary ASCENT-04 data ...

Alpha Tau Medical Sets Up Catalyst-Rich 2026 as Key Cancer Trial Data Nears

Alpha Tau Medical (NASDAQ:DRTS) outlined a series of clinical and regulatory updates during the Lytham Partners Spring 2026 Investor Conference, with Raphi Levy of Alpha Tau telling investors the ...